Showing results (651-660 of 5,988) with videos related to

Sort By:
Pageof 599
Molecular Psychiatry|October 16, 2013
Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effectsG Sanacora, M A Smith, S Pathak, et al.
Molecular Psychiatry|December 18, 2013
Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT)T Lencz, E Knowles, G Davies, et al.
Molecular Psychiatry|April 2, 2009
Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey ReplicationM K Nock, I Hwang, N A Sampson, et al.
Molecular Psychiatry|November 5, 2008
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorderM Kato, A Serretti
Molecular Psychiatry|September 13, 2007
Advances in behavioral genetics: mouse models of autismS S Moy, J J Nadler
Molecular Psychiatry|September 13, 2007
Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicideS Dracheva, N Patel, D A Woo, et al.
Molecular Psychiatry|September 4, 2007
Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expressionR E Straub, B K Lipska, M F Egan, et al.
Molecular Psychiatry|May 19, 2010
A genetic determinant of the striatal dopamine response to alcohol in menV A Ramchandani, J Umhau, F J Pavon, et al.
Molecular Psychiatry|May 19, 2010
Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depressionR C Shelton, J Claiborne, M Sidoryk-Wegrzynowicz, et al.
Molecular Psychiatry|April 7, 2010
Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorderH J Williams, N Norton, S Dwyer, et al.
Pageof 599